170 related articles for article (PubMed ID: 15086042)
1. Atypical pathogens and challenges in community-acquired pneumonia.
Thibodeau KP; Viera AJ
Am Fam Physician; 2004 Apr; 69(7):1699-706. PubMed ID: 15086042
[TBL] [Abstract][Full Text] [Related]
2. Community-acquired pneumonia in adults.
Sue DY
West J Med; 1994 Oct; 161(4):383-9. PubMed ID: 7817549
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of community-acquired pneumonia in adults.
Watkins RR; Lemonovich TL
Am Fam Physician; 2011 Jun; 83(11):1299-306. PubMed ID: 21661712
[TBL] [Abstract][Full Text] [Related]
4. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
[TBL] [Abstract][Full Text] [Related]
5. Community-acquired pneumonia in adults: initial antibiotic therapy.
King DE; Pippin HJ
Am Fam Physician; 1997 Aug; 56(2):544-50. PubMed ID: 9262534
[TBL] [Abstract][Full Text] [Related]
6. Acute community-acquired pneumonia: current diagnosis and treatment.
Bryan CS
J S C Med Assoc; 2001 Jan; 97(1):19-26. PubMed ID: 11227252
[TBL] [Abstract][Full Text] [Related]
7. [What is new in the treatment of community-acquired pneumonia?].
Welte T; Marre R; Suttorp N;
Med Klin (Munich); 2006 Apr; 101(4):313-20. PubMed ID: 16607488
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
[TBL] [Abstract][Full Text] [Related]
9. [Treatment and course of community-acquired pneumonia caused by atypical pathogens].
Fernández Alvarez R; Suárez Toste I; Rubinos Cuadrado G; Medina Gonzálvez A; Gullón Blanco JA; González Martín I
Arch Bronconeumol; 2006 Sep; 42(9):430-3. PubMed ID: 17040657
[TBL] [Abstract][Full Text] [Related]
10. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.
Bartlett JG
Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295
[TBL] [Abstract][Full Text] [Related]
11. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.
Segreti J; House HR; Siegel RE
Am J Med; 2005 Jul; 118 Suppl 7A():21S-28S. PubMed ID: 15993674
[TBL] [Abstract][Full Text] [Related]
12. Etiology of community-acquired pneumonia in hospitalized patients in Jordan.
Al-Ali MK; Batchoun RG; Al-Nour TM
Saudi Med J; 2006 Jun; 27(6):813-6. PubMed ID: 16758041
[TBL] [Abstract][Full Text] [Related]
13. Patterns of health care resource utilization after macrolide treatment failure: results from a large, population-based cohort with acute sinusitis, acute bronchitis, and community-acquired pneumonia.
Wu JH; Howard DH; McGowan JE; Frau LM; Dai WS
Clin Ther; 2004 Dec; 26(12):2153-62. PubMed ID: 15823779
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
Feldman C
J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical presentations of atypical pathogens infection in community acquired pneumonia in Thailand.
Prapphal N; Suwanjutha S; Durongkaveroj P; Lochindarat S; Kunakorn M; Deerojanawong J; Chantarojanasiri T; Supanitayaonon Y; Janedittakarn P
J Med Assoc Thai; 2006 Sep; 89(9):1412-9. PubMed ID: 17100378
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial treatment of lower respiratory tract infections in the hospital setting.
Grossman RF; Rotschafer JC; Tan JS
Am J Med; 2005 Jul; 118 Suppl 7A():29S-38S. PubMed ID: 15993675
[TBL] [Abstract][Full Text] [Related]
17. [Anglo-Saxon guidelines for the treatment of community-acquired pneumonia applicable in The Netherlands as well].
Hoepelman IM; Sachs AP; Visser MR; Lammers JW
Ned Tijdschr Geneeskd; 1997 Aug; 141(33):1597-601. PubMed ID: 9543764
[TBL] [Abstract][Full Text] [Related]
18. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
19. Empiric antibiotic prescribing for patients with community-acquired pneumonia: where can we improve?
Buising KL; Thursky KA; Black JF; Macgregor L; Street AC; Kennedy MP; Brown GV
Intern Med J; 2008 Mar; 38(3):174-7. PubMed ID: 18290813
[TBL] [Abstract][Full Text] [Related]
20. Lower respiratory tract infections and community acquired pneumonia in adults.
Stocks N; Turnidge J; Crockett A
Aust Fam Physician; 2004 May; 33(5):297-301. PubMed ID: 15227857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
